Ampio Pharmaceuticals Inc (AMPE)
0.252
-0.08
(-23.64%)
USD |
OTCM |
May 02, 15:42
Ampio Pharmaceuticals Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.111M |
| December 31, 2021 | 20.48M |
| September 30, 2021 | 0.495M |
| June 30, 2021 | 7.073M |
| March 31, 2021 | 2.686M |
| December 31, 2020 | 10.88M |
| September 30, 2020 | 7.273M |
| June 30, 2020 | 7.017M |
| March 31, 2020 | 0.436M |
| December 31, 2019 | 3.247M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 11.08M |
| March 31, 2019 | 0.02M |
| December 31, 2018 | 1.318M |
| September 30, 2018 | 7.265M |
| June 30, 2018 | 0.3953M |
| March 31, 2018 | 3.101M |
| December 31, 2017 | 9.013M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0124M |
| June 30, 2017 | 5.770M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.0655M |
| September 30, 2016 | 3.463M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 16.30M |
| September 30, 2015 | 4.877M |
| June 30, 2015 | -0.0187M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 5.521M |
| September 30, 2014 | -0.033M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 63.44M |
| December 31, 2013 | 0.2955M |
| September 30, 2013 | 25.01M |
| June 30, 2013 | 1.068M |
| March 31, 2013 | 3.056M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 15.37M |
| June 30, 2012 | 0.618M |
| March 31, 2012 | 0.0369M |
| December 31, 2011 | 8.500M |
| September 30, 2011 | 0.1942M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.111M
Minimum
Mar 2022
20.48M
Maximum
Dec 2021
3.714M
Average
0.436M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -0.1745M |
| Tivic Health Systems Inc | 0.00 |
| Oragenics Inc | -0.1806M |
| Actinium Pharmaceuticals Inc | 14.77M |
| MAIA Biotechnology Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.309M |
| Free Cash Flow | -8.564M |
| Free Cash Flow Per Share (Quarterly) | -2.789 |
| Free Cash Flow Yield | -4.33K% |